mc.duke.edu ABOARD randomised controlled trial No difference in peak troponin level in immediate versus delayed (next working day) intervention for acute coronary syndrome without ST-segment elevation Patients with high-risk acute coronary syndromes have been shown to benefi t from a strategy of early invasive catheterisation, and this is refl ected in the US and European guidelines. However, the recently reported long-term fol-low-up from the Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) trial shows that even patients with elevated troponin may not benefi t sub-stantially from an early invasive strategy, compared with a “selective invasive ” strategy, in the context of optimum medical therapy.1 Selected tria...
ObjectivesWe present the 5-year clinical outcomes according to treatment strategy with additional ri...
International audienceThe aim of this study was to compare an early versus a delayed invasive strate...
Objective Patients with non-ST elevation acute coronary syndrome (NSTE-ACS) benefit from coronary in...
International audienceCONTEXT: International guidelines recommend an early invasive strategy for pat...
Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortal...
OBJECTIVE: To determine whether routine coronary angiography followed by revascularisation where app...
Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortal...
BACKGROUND: The ICTUS trial was a study that compared an early invasive with a selective invasive tr...
Background The ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial c...
BACKGROUND: The ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial ...
AimTo determine the optimal timing of catheterization in high risk acute coronary syndromes.MethodsT...
BACKGROUND: Current guidelines recommend an early invasive strategy for patients who have acute coro...
Studies have indicated that an early invasive strategy is favorable over a selective invasive strate...
International audienceAccording to recent literature, pretreatment with a P2Y12 ADP receptor antagon...
Invasive coronary revascularization has been shown to improve prognoses in patients with non-ST-segm...
ObjectivesWe present the 5-year clinical outcomes according to treatment strategy with additional ri...
International audienceThe aim of this study was to compare an early versus a delayed invasive strate...
Objective Patients with non-ST elevation acute coronary syndrome (NSTE-ACS) benefit from coronary in...
International audienceCONTEXT: International guidelines recommend an early invasive strategy for pat...
Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortal...
OBJECTIVE: To determine whether routine coronary angiography followed by revascularisation where app...
Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortal...
BACKGROUND: The ICTUS trial was a study that compared an early invasive with a selective invasive tr...
Background The ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial c...
BACKGROUND: The ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial ...
AimTo determine the optimal timing of catheterization in high risk acute coronary syndromes.MethodsT...
BACKGROUND: Current guidelines recommend an early invasive strategy for patients who have acute coro...
Studies have indicated that an early invasive strategy is favorable over a selective invasive strate...
International audienceAccording to recent literature, pretreatment with a P2Y12 ADP receptor antagon...
Invasive coronary revascularization has been shown to improve prognoses in patients with non-ST-segm...
ObjectivesWe present the 5-year clinical outcomes according to treatment strategy with additional ri...
International audienceThe aim of this study was to compare an early versus a delayed invasive strate...
Objective Patients with non-ST elevation acute coronary syndrome (NSTE-ACS) benefit from coronary in...